Your browser doesn't support javascript.
loading
Systemic consequences of abnormal cholesterol handling: Interdependent pathways of inflammation and dyslipidemia.
O'Hagan, Ross; Berg, Alex R; Hong, Christin G; Parel, Philip M; Mehta, Nehal N; Teague, Heather L.
Afiliação
  • O'Hagan R; Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States.
  • Berg AR; Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States.
  • Hong CG; Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States.
  • Parel PM; Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States.
  • Mehta NN; Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States.
  • Teague HL; Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States.
Front Immunol ; 13: 972140, 2022.
Article em En | MEDLINE | ID: mdl-36091062

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Dislipidemias Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Dislipidemias Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article